In the literature review, it was found thatserum Asprosin levels were examined in some diseases, such as polycystic ovarysyndrome and obesity besides CAD and diabetes, and it was emphasized that it mightbe a biochemical marker[20]. This evidence concerns the gene FBN1 and Obesity.